We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+2.21%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$165M
AUM Growth
-$28.9M
Cap. Flow
-$31.4M
Cap. Flow %
-18.98%
Top 10 Hldgs %
45.86%
Holding
78
New
22
Increased
10
Reduced
11
Closed
34

Sector Composition

Rank Sector Weight
1 Communication Services 21.89%
2 Consumer Discretionary 19.14%
3 Healthcare 13.65%
4 Technology 12.38%
5 Materials 11.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTHR icon
26
CALL
United Therapeutics
UTHR
$25.8B
$2.51M 1.52%
+22,500
New +$2.85M
EPAM icon
27
EPAM Systems
EPAM
$5.51B
$2.46M 1.49%
33,000
-12,000
-27% -$829K
TCOM icon
28
Trip.com Group
TCOM
$29.6B
$2.35M 1.42%
53,000
-3,500
-6% -$146K
GDX icon
29
VanEck Gold Miners ETF
GDX
$22.7B
$2.33M 1.41%
+116,500
New +$2M
STZ icon
30
Constellation Brands
STZ
$22.2B
$2.27M 1.37%
+15,000
New +$2.17M
TPR icon
31
Tapestry
TPR
$30.8B
$2.21M 1.33%
+55,000
New +$1.99M
GRA
32
CALL
DELISTED
W.R. Grace & Co.
GRA
$2.14M 1.29%
+30,000
New +$2.29M
AET
33
DELISTED
Aetna Inc
AET
$2.02M 1.22%
18,000
+1,000
+6% +$107K
MTN icon
34
Vail Resorts
MTN
$5.32B
$2M 1.21%
15,000
-900
-6% -$113K
BMRN icon
35
BioMarin Pharmaceuticals
BMRN
$11.6B
$1.98M 1.2%
24,000
+22,000
+1,100% +$1.79M
SHAK icon
36
Shake Shack
SHAK
$2.53B
$1.79M 1.08%
+48,000
New +$1.73M
LLY icon
37
CALL
Eli Lilly
LLY
$1.02T
$1.73M 1.04%
24,000
-42,000
-64% -$3.18M
BIDU icon
38
Baidu
BIDU
$37.7B
$1.53M 0.92%
+8,000
New +$1.36M
DNKN
39
DELISTED
Dunkin' Brands Group, Inc.
DNKN
$1.42M 0.86%
+30,000
New +$1.29M
AGN
40
DELISTED
Allergan plc
AGN
$1.34M 0.81%
5,000
-16,090
-76% -$4.61M
EW icon
41
Edwards Lifesciences
EW
$49.6B
$1.23M 0.75%
+42,000
New +$1.16M
PTLA
42
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$561K 0.34%
27,500
-38,500
-58% -$1.22M
NVCR icon
43
CALL
NovoCure
NVCR
$1.73B
$365K 0.22%
+25,200
New +$362K
ACAD icon
44
CALL
Acadia Pharmaceuticals
ACAD
$4.43B
$288K 0.17%
10,300
ALKS icon
45
Alkermes
ALKS
$8.22B
-25,500
Closed -$2.02M
AMZN icon
46
Amazon
AMZN
$2.92T
-60,000
Closed -$2.03M
BBSI icon
47
Barrett Business Services
BBSI
$959M
-124,000
Closed -$1.35M
BMY icon
48
Bristol-Myers Squibb
BMY
$133B
-62,500
Closed -$4.3M
DLTR icon
49
Dollar Tree
DLTR
$24.4B
-37,000
Closed -$2.86M
LKFT
50
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
-42,000
Closed -$2.64M

Similar funds

Atika Capital Management's Q1 2016 Portfolio in Review

As of Q1 2016, Atika Capital Management held 78 positions worth $165M, down 15% from $194M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Atika Capital Management withdrew a net $31.4M in Q1 2016, closing 34 positions and reducing 11 holdings. Its most notable exit was McDonald's, an estimated $7.81M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 22% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Atika Capital Management opened a new position in Home Depot worth $6.8M.

  • Atika Capital Management's largest Q1 2016 buy was Home Depot: 51,000 shares worth $6.8M.
  • Atika Capital Management added most to Walgreens Boots Alliance in Q1 2016, an estimated $3.66M increase.
  • Atika Capital Management's biggest Q1 2016 reduction was Alphabet (Google) Class C, cutting an estimated $7.52M.
  • Atika Capital Management fully exited McDonald's in Q1 2016, selling an estimated $7.81M.
  • Atika Capital Management's ten largest holdings make up 46% of its $165M portfolio in Q1 2016.
  • Atika Capital Management opened 22 new positions and closed 34 in Q1 2016.
  • Atika Capital Management's portfolio value fell 15% quarter-over-quarter to $165M.

Based on Atika Capital Management's 13F filing for Q1 2016, filed 16 May 2016.